The 16 references in paper A. Erlikh D., А. Эрлих Д. (2017) “НЕКОТОРЫЕ АСПЕКТЫ ПОВЫШЕНИЯ ПРИВЕРЖЕННОСТИ ДВОЙНОЙ АНТИТРОМБОЦИТАРНОЙ ТЕРАПИИ ПОСЛЕ ОСТРОГО КОРОНАРНОГО СИНДРОМА // SOME ASPECTS OF IMPROVING ADHERENCE TO DUAL ANTITHROMBOTIC THERAPY AFTER ACUTE CORONARY SYNDROME” / spz:neicon:aterotromboz:y:2017:i:1:p:44-52

1
Wallentin L, Becker RC, Budaj A. Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA for the PLATO Investigators. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes. N Engl J Med,2009, 361: 1045-1057.
(check this in PDF content)
2
Jernberg T, Hjelm H, Hasvold P et al. Continued high CVD risk in myocardial infarction survivors: comparison of risk first and second year after MI — results from a Swedish nationwide study. Eur Heart J, 2014,
(check this in PDF content)
3
Suppl. 1): 363. 3. Nakatani D, Sakata Y, Suna S, Usami M, Matsumoto S, Shimizu M, Sumitsuji S, Kawano S, Ueda Y, Hamasaki T, Sato H, Nanto S, Hori M, Komuro I, Osaka Acute Coronary Insufficiency Study (OACIS) Investigators. Incidence, predictors, and subsequent mortality risk of recurrent myocardial infarction in patients following discharge for acute myocardial infarction. Circ J. 2013, 77(2): 439-46.
(check this in PDF content)
4
Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, Mehran R, McPherson J, Farhat N, Marso SP, Parise H, Templin B, White R, Zhang Z, Serruys PW, PROSPECT Investigators. A prospective natural-history study of coronary atherosclerosis. N Engl J Med, 2011 Jan 20, 364(3): 226-35.
(check this in PDF content)
5
Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, Granger CB, Lange RA, Mack MJ, Mauri L, Mehran R, Mukherjee D, Newby LK, O’Gara PT, Sabatine MS, Smith PK, Smith SC Jr. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Gu
(check this in PDF content)
6
Rossini R, Capodanno D, Lettieri C, Musumeci G, Nijaradze T, Romano M, Lortkipanidze N, Cicorella N, Biondi Zoccai G, Sirbu V, Izzo A, Guagliumi G, Valsecchi O, Gavazzi A, Angiolillo DJ. Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation. Am J Cardiol, 2011 Jan 15, 107(2): 186-94.
(check this in PDF content)
7
Mehran R, Baber U, Steg PG et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet,2013. http: //dx.doi.org/10.1016/S0140— 6736(13)61720-1.
(check this in PDF content)
8
Mahmoud KD, Sanon S, Habermann EB, Lennon RJ, Thomsen KM, Wood DL, Zijlstra F, Frye RL, Holmes DR Jr Perioperative Cardiovascular Risk of Prior Coronary Stent Implantation Among Patients Undergoing Noncardiac Surgery. J Am Coll Cardiol, 2016 Mar, 67(9): 1038-49.
(check this in PDF content)
9
Dimitrova G, Tulman DB, Bergese SD. Perioperative management of antiplatelet therapy in patients with drug-eluting stents. HSR Proc Intensive Care Cardiovasc Anesth, 2012, 4(3): 153-67.
(check this in PDF content)
10
ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation,2007 Oct 23, 116(17): 1971-96.
(check this in PDF content)
11
Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation, 2006 Aug 22, 114(8): 774-82.
(check this in PDF content)
12
Hicks KA, Stockbridge NL, Targum SL, Temple RJ. Bleeding Academic Research Consortium Consensus Report The Food and Drug Administration Perspective. Circulation,2011, 123: 2664-2665.
(check this in PDF content)
13
Ferreira-GonzЗlez I, Marsal JR, Ribera A, PermanyerMiralda G, GarcТa-Del Blanco B, MartТ G, Cascant P, Masotti-Centol M, Carrillo X, Mauri J, Batalla N, Larrousse E, MartТn E, Serra A, Rumoroso JR, RuizSalmerЧn R, de la Torre JM, Cequier A, GЧmezHospital JA, Alfonso F, MartТn-Yuste V, SabatП M, GarcТa-Dorado D. Double antiplatelet therapy after drug-eluting stent implantation: risk associated with discontinuation within the first year. J Am Coll Cardiol, 2012 Oct 9,60(15): 1333-9.
(check this in PDF content)
14
SahlОn A, Varenhorst C, Lagerqvist B, Renlund H, Omerovic E, Erlinge D, Wallentin L, James SK, Jernberg T. Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry. Eur Heart J, 2016, 37(44): 3335-3342.
(check this in PDF content)
15
Storey RF, Becker RC, Harrington RA, Husted S, James SK, Cools F, Steg PG, Khurmi NS, Emanuelsson H, Cooper A, Cairns R, Cannon CP, Wallentin L. Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes. Eur Heart J, 2011 Dec, 32(23): 2945-53.
(check this in PDF content)
16
Bonaca MP, Bhatt DL, Ophuis TO, Steg PG, Storey R, Cohen M, Kuder J, Im K, Magnani G, Budaj A, Theroux P, Hamm C, Spinar J, Kiss RG, Dalby AJ, Medina FA, Kontny F, Aylward FE, Jensen EC, Held P, Braunwald E, Sabatine MS. Long-term Tolerability of
(check this in PDF content)